Hemato Oncology Testing Market: By Product & Service, By Cancer Type, By Technology, By End User, and Geography  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Hemato Oncology Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product & Service (Services and Assay kit), By Cancer Type (Leukemia, Acute myeloid leukemia, Acute lymphocytic leukemia, Lymphoma, Non-Hodgkin lymphoma, Hodgkin lymphoma, and others), By Technology (PCR, IHC, NGS, Cytogenetics, and others), By End User (Clinical laboratories, Hospitals, Academic & Research institute, and others), and Region  

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Hemato Oncology Testing Market size was valued at 2.5 billion in 2023 and is poised to grow at a CAGR of 14.8% from 2024to 2030. There is a high rise in the number of patients suffering from blood and tumor diseases, which has been the key reason for substantial growth in the hemato-oncology market. Growing hematological cancer prevalence, developing partnerships to create new assays, and growing knowledge of customized medicines. In addition, the recent increase in the geriatric population is another integral factor driving the global demand for hemato-oncology. However, it is expected that unclear reimbursements in various regions will hinder market development. The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.

summary download arrow Download Free Sample

Hemato Oncology Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

14.8%

Largest Market

Europe

Fastest Growing Market

North-America

Hemato Oncology Testing Market Dynamics

The key trend is the discovery and development of new tests and therapies, with companies operating in the global market for hemato oncology testing continuing to compete. Their growing engagement in partnerships and alliances is proving to be very advantageous for the growth of the business. Nonetheless, the high demand for PCR and NGS technologies for testing and diagnosis of hemato oncology would in the long run normalize the effect of these restricting factors.

Hemato Oncology Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market CAGR

14.8%

By Product Type

  • Services
  • Assay kits

By Cancer Type

  • Leukemia
  • Acute myeloid leukemia
  • Acute lymphocytic leukemia
  • Lymphoma
  • Non-Hodgkin lymphoma
  • Hodgkin lymphoma
  • Others

By Technology

  • PCR
  • IHC
  • NGS
  • Cytogenetics
  • Others

By End User

  • Clinical laboratories
  • Hospitals
  • Academic & Research Institutes
  • Other End Users

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The hemato oncology testing market size was valued at US$ 2.5 billion in 2023

Increasing Incidence of Hematologic Cancer Source

North America is the fastest-growing for hemato oncology testing market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Hemato Oncology Testing Market Introduction 
2.1.Global Hemato Oncology Testing Market  - Taxonomy
2.2.Global Hemato Oncology Testing Market  - Definitions
2.2.1.Product Type
2.2.2.Cancer Type
2.2.3.Technology
2.2.4.End User
2.2.5.Region
3. Global Hemato Oncology Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Hemato Oncology Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Hemato Oncology Testing Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Services
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Assay kits
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Global Hemato Oncology Testing Market  By Cancer Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Leukemia
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Acute myeloid leukemia
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Acute lymphocytic leukemia
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Lymphoma
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Non-Hodgkin lymphoma
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Hodgkin lymphoma
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7. Global Hemato Oncology Testing Market  By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. PCR
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. IHC
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. NGS
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Cytogenetics
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. Global Hemato Oncology Testing Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Clinical laboratories
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Hospitals
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Academic & Research Institutes
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Other End Users
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Hemato Oncology Testing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Hemato Oncology Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Services
10.1.2.Assay kits
10.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Leukemia
10.2.2.Acute myeloid leukemia
10.2.3.Acute lymphocytic leukemia
10.2.4.Lymphoma
10.2.5.Non-Hodgkin lymphoma
10.2.6.Hodgkin lymphoma
10.2.7.Others
10.3.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.PCR
10.3.2.IHC
10.3.3.NGS
10.3.4.Cytogenetics
10.3.5.Others
10.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Clinical laboratories
10.4.2.Hospitals
10.4.3.Academic & Research Institutes
10.4.4.Other End Users
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Hemato Oncology Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Services
11.1.2.Assay kits
11.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Leukemia
11.2.2.Acute myeloid leukemia
11.2.3.Acute lymphocytic leukemia
11.2.4.Lymphoma
11.2.5.Non-Hodgkin lymphoma
11.2.6.Hodgkin lymphoma
11.2.7.Others
11.3.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.PCR
11.3.2.IHC
11.3.3.NGS
11.3.4.Cytogenetics
11.3.5.Others
11.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Clinical laboratories
11.4.2.Hospitals
11.4.3.Academic & Research Institutes
11.4.4.Other End Users
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Hemato Oncology Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Services
12.1.2.Assay kits
12.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Leukemia
12.2.2.Acute myeloid leukemia
12.2.3.Acute lymphocytic leukemia
12.2.4.Lymphoma
12.2.5.Non-Hodgkin lymphoma
12.2.6.Hodgkin lymphoma
12.2.7.Others
12.3.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.PCR
12.3.2.IHC
12.3.3.NGS
12.3.4.Cytogenetics
12.3.5.Others
12.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Clinical laboratories
12.4.2.Hospitals
12.4.3.Academic & Research Institutes
12.4.4.Other End Users
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Hemato Oncology Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Services
13.1.2.Assay kits
13.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Leukemia
13.2.2.Acute myeloid leukemia
13.2.3.Acute lymphocytic leukemia
13.2.4.Lymphoma
13.2.5.Non-Hodgkin lymphoma
13.2.6.Hodgkin lymphoma
13.2.7.Others
13.3.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.PCR
13.3.2.IHC
13.3.3.NGS
13.3.4.Cytogenetics
13.3.5.Others
13.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Clinical laboratories
13.4.2.Hospitals
13.4.3.Academic & Research Institutes
13.4.4.Other End Users
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Hemato Oncology Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Services
14.1.2.Assay kits
14.2.  Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Leukemia
14.2.2.Acute myeloid leukemia
14.2.3.Acute lymphocytic leukemia
14.2.4.Lymphoma
14.2.5.Non-Hodgkin lymphoma
14.2.6.Hodgkin lymphoma
14.2.7.Others
14.3.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.PCR
14.3.2.IHC
14.3.3.NGS
14.3.4.Cytogenetics
14.3.5.Others
14.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Clinical laboratories
14.4.2.Hospitals
14.4.3.Academic & Research Institutes
14.4.4.Other End Users
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Hoffmann-La Roche Ltd.
15.2.2.Abbott Laboratories
15.2.3.Thermo Fisher Scientific Inc.
15.2.4.QIAGEN N.V.
15.2.5.Bio-Rad Laboratories Inc.
15.2.6.Illumina Inc.
15.2.7.MolecularMD
15.2.8.Invivoscribe Inc.
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

 

  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • MolecularMD
  • Invivoscribe Inc.
  • Asuragen Inc.
  • ArcherDX Inc.

Related Industry Reports

Egypt Diabetes Devices Market

Lithuania Surgical Equipment Market

Antimicrobials Market

Cancer Therapy Market